The largest database of trusted experimental protocols

Hitrap q hp column

Manufactured by Cytiva
Sourced in United States

The HiTrap Q HP column is a prepacked anion exchange chromatography column designed for fast and efficient purification of proteins and other biomolecules. It features a high-performance agarose-based resin with a strong anion exchange ligand, providing high binding capacity and resolution.

Automatically generated - may contain errors

28 protocols using hitrap q hp column

1

Extraction and Purification of Membrane Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
BamA, OmpT, or the OmpT mutants G216K,K217G and D105A were expressed in inclusion bodies following the protocol above, except that the cell pellets obtained from harvesting the cultures were used. Cells homogenized in lysis buffer containing 20 mM Tris-Cl, pH 8.0, DNase, PMSF and lysozyme were incubated at room temperature for 20 min and then lysed in a high-pressure microfluidizer. Lysed cells were centrifuged at 12,000 g for 10 min to collect the inclusion bodies, which were washed in 20 mM Tris-Cl, pH 8.0 with 0.1% Triton-X 100 and then dissolved in 6 M Gn-HCl. The solution was centrifuged at 12,000 g for 10 min at room temperature and the supernatant was dialyzed overnight in a 10 kDa membrane filter against water. The membrane protein of interest precipitated out during this dialysis and was then dissolved in 20 mM Tris-Cl, pH 8.0 containing 7 M urea. Unfolded BamA and OmpT were further purified by cation exchange chromatography using a HiTrap Q-HP column (Cytiva) and eluted in a gradient of 1 M NaCl in 20 mM Tris-Cl, pH 8.0 containing 7 M urea. Purified proteins were directly flash-frozen in liquid nitrogen and stored at –80 °C.
+ Open protocol
+ Expand
2

Purification and Characterization of ASF1 Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Supernatant containing ASF1 (1 to 160) was incubated with amylose resin (New England BioLabs), washed with buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 20% glycerol, and eluted by cleavage with TEV protease. The eluted ASF1 sample was further purified by anion exchange using an HiTrap Q HP column (Cytiva) and concentrated for injection onto a size-exclusion column that was preequilibrated with buffer containing 30 mM Tris (pH 8.0), 150 mM NaCl, and 10% glycerol.
+ Open protocol
+ Expand
3

Ubiquitin-BRD1732 Conjugate Purification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ubiquitin-BRD1732 conjugate was prepared by following steps. Expi293T cells were grown in in 125-mL shaker flasks at 37°C and 8% CO2. Cells were transiently transfected with pLVX6 RNF19A using the ExpiFectamine 293 Transfection Kit following the manufacturer’s instructions. After incubation overnight, media was exchanged to Expi293 Expression Media containing 10 μM BRD1732 and cells were incubated for 6 hours. The cell stock was then resuspended with cell lysis reagent CelLytic M (Sigma-Aldrich) supplemented with EDTA-free protease inhibitor cocktail tablet (Sigma-Aldrich) and incubated for 40 min at 4°C on a shaker. The sample were then centrifuged at 1,200 × g for 2 min using table centrifuge. The supernatant was collected and filtered using 0.45 μm filter (Millex) before loading on 1 mL HiTrap Q HP column (Cytiva) using fast protein liquid chromatography (FPLC) on ÄKTA pure (Cytiva). Ubiquitin-BRD1732 conjugate were eluted with a salt gradient from 0 to 1 M NaCl in 50 mM ammonium chloride, pH 6.0. The pooled protein sample was further purified by size-exclusion chromatography (SEC) using a Superdex 75 Increase 10/300 GL (Cytiva) column in PBS buffer. In comparison, wild-type ubiquitin was purified from Expi293T cells using the same mentioned-above method except the steps of pLVX6 plasmid transfection and BRD1732-treatment.
+ Open protocol
+ Expand
4

Cofactor Determination of C4-Reductases

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cofactors bound to the as-purified C4-reductases were determined by anion exchange chromatography and mass spectrometry. The proteins were diluted to a final concentration of 400 μM and then heat-denatured (95 °C for 60 s) to release the bound cofactor. The supernatant solution was collected after centrifugation at 10,000 × g for 10 min. The residual denatured protein was removed using a 0.5 mL spin-filter with a 10 kDa molecular weight cutoff. The resulting flow-through was injected onto a BioRad FPLC system equipped with a 1.0 mL HiTrap Q HP column (Cytiva). The column was washed with water, and the cofactors were eluted with a linear gradient of 500 mM ammonium bicarbonate. The elution was monitored by changes in absorbance at 255 nm and quantified by integration of relative peak area. A control chromatogram was collected using known concentrations (200 μM) of NAD+, NADH, NADP+, and NADPH.
+ Open protocol
+ Expand
5

Purification of Suc1 from S. pombe

Check if the same lab product or an alternative is used in the 5 most similar protocols
A cDNA encoding Schizosaccharomyces pombe Suc1 (provided by Eiichi Okumura [Tokyo Institute of Technology, Japan]) was cloned into the pET28-3C vector. Protein expression in the E. coli host and coarse purification using a Ni2+-charged column were performed as described above. The resultant suc1 fused with a His tag at their N-terminus was purified by using a Ni2+-charged Chelating Sepharose Fast Flow column. Peak fractions were pooled, further purified with a HiTrap Q HP column (Cytiva, 17115301), and dialyzed against buffer KHG150/10. Typically, 10 mg protein was obtained from a 1-liter culture and the concentration of stock aliquots ranged from 200 μM to 500 μM.
+ Open protocol
+ Expand
6

Purification and Characterization of Wall Teichoic Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols
WTA were extracted from purified cell walls with TCA as described previously (Tomita et al., 2009 (link)) with some modifications. Briefly, lyophilized cell walls (50 mg; prepared as described above, keeping pH < 6.0 to avoid D-Ala hydrolysis from WTA) were incubated with 1 mL of 10% TCA at 4°C for 48 hr under rotation. The suspension was then centrifuged at 20.000 × g for 20 min at 4°C and the supernatant was recovered. WTAs were precipitated by addition of 5 V of ethanol and incubation overnight at –20°C. The pellet was purified by resuspension in TCA 10% and precipitation with ethanol. The final pellet was washed twice with cold ethanol, and the pellet was resuspended in MilliQ H2O and lyophilized. WTAs were resuspended in 100 mM ammonium acetate buffer pH 4.8 (buffer A) and purified by anion exchange chromatography on a 1 mL HiTrap Q HP column (Cytiva) equilibrated with buffer A. WTAs were eluted with a gradient from 0 to 100% buffer B (buffer A containing 1 M NaCl) in 20 min. Fractions were collected and the presence of WTA was assessed in microplates with thymol-H2SO4 reagent (Engelhardt and Ohs, 1987 (link)), allowing detection of hexoses substituents of WTAs. The WTA-containing fractions were pooled and dialyzed against 10 mM ammonium acetate pH 4.8 with Float-a-Lyzer G2 dialysis devices (cut-off 500–1000 Da) (Spectra/Por) and lyophilized.
+ Open protocol
+ Expand
7

Purification of AtUBA1 Protein from E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Arabidopsis thaliana UBA1 open reading frame was cloned into the NdeI and XhoI sites of pET23a(+) in frame with the C-terminal His6 tag by commercial gene synthesis (Genscript). AtUBA1 was expressed as a His6-tagged protein from pET23a in E. coli BL21-AITM (InvitrogenTM) at 18°C for 20 h with 800 µM IPTG and 0.2% (w/v) L-arabinose. AtUBA1 was purified by Immobilised Metal Affinity Chromatography (IMAC). The protein was purified using a HisTrap HP column (1 mL, Cytiva) and an equilibration buffer of 50 mM Tris-HCl pH 7.5, 400 mM NaCl, and 20 mM imidazole. The wash and elution buffers consisted of 50 mM Tris-HCl, 400 mM NaCl and 40 mM/200 mM imidazole. AtUBA1-containing fractions were dialysed into anion exchange start buffer (50 mM Tris-HCl, 50 mM NaCl, 1 mM DTT, 5% (v/v) glycerol) and purified using a HiTrap Q HP column (1 mL, Cytiva). The protein was eluted using a NaCl gradient (50-500 mM), and the resulting fractions were analysed by SDS-PAGE. AtUBA1 containing fractions were dialysed into size exclusion chromatography buffer (50 mM Tris-HCl, 200 mM NaCl, 1 mM DTT, 15% (v/v) glycerol), concentrated and then further purified by size exclusion chromatography on a 16/600 Superdex 200 pg column (GE Lifesciences) and an AKTA Pure chromatography system.
+ Open protocol
+ Expand
8

HLA-DP1 Peptide Exchange Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A 17-mer pp65 peptide (denoted as peptide 2) was synthesized by GL Biochem (China). The integrity of the peptides was verified by reverse-phase HPLC and mass spectrometry. HLA-DP1 was digested with Factor Xa (New England BioLabs, MA, USA) in the presence of 2 mM CaCl2 to cleave the covalently linked Strep-TagII-CLIP peptide (WSHPQFEKGAPVSKMRMATPLLMQAGSGGSIEGRGSGSG). The Strep-TagII-CLIP peptide in HLA-DP1 was exchanged with the pp65142–158 peptide using a 20-fold molar excess of peptide to HLA-DP1 in a buffer comprising 50 mM trisodium citrate pH 5.4 and 5 mM EDTA at 37°C for 24–72 h in the presence of HLA-DM (1:5 molar ratio HLA-DM:HLA-DP1). Peptide 2–loaded HLA-DP1 was separated from unloaded HLA-DP1-Strep-TagII-CLIP using Strep-Tactin Sepharose (IBA, Gottingen, Germany). Peptide 2–HLA-DP1 was subjected to 3C protease cleavage in order to remove the Fos/Jun leucine zippers and further purified using anion exchange (HiTrap Q HP column; Cytiva) chromatography. Final purified proteins were pooled and concentrated to 10 mg/ml.
+ Open protocol
+ Expand
9

Purification of Complementary DNA Strands

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single-stranded DNA oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA) with standard desalting purification. The lyophilized oligos were resuspended in MilliQ water. Equimolar quantities of the complementary strands were combined, and concentrated stocks of Tris (pH 7) and NaCl were added to concentrations of 10 mM and 100 mM, respectively. Annealing was performed by placing the mixture in a water bath at 95 °C, shutting off the heat, and cooling gradually in the water bath overnight. The annealed oligos were further purified using anion exchange chromatography with a HiTrap QHP column (Cytiva). FPLC fractions were concentrated using a Macrosep 1k MWCO centrifugal filter (Pall) at 4 °C.
+ Open protocol
+ Expand
10

Purification and Characterization of ADP-Ribosylated Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
P14 (8 µM) was incubated with 4 mM NAD+ and either P14p6 or P14p8 (115 µM) for 2 h at room temperature in a 420 µL reaction volume consisting of 50 mM HEPES, pH 7.5, 400 mM NaCl, 2.5% glycerol, and 0.4 mM β-mercaptoethanol. At 30 min an additional 11.8 µL of concentrated P14 (285 µM) was added. The reaction was diluted to 1 mL in an SE buffer (10 mM potassium phosphate, pH 6.0 and 25 mM NaCl) and subjected to size exclusion chromatography at a rate of 0.75 mL/min using a Superdex Peptide 10/300 GL column (Cytiva, Marlborough, MA, USA) while collecting 250 µL fractions. MAR–peptide-containing fractions were pooled and brought up to 5 mL in an IE buffer (10 mM BIS-Tris, pH 5.0 and 25 mM NaCl) and further purified using anion exchange chromatography with a HiTrap Q HP column (Cytiva) and exchanged into an IE buffer + 1 M NaCl. ADPr–peptide fractions were desalted using a Sep-Pak C18 cartridge (Waters, Milford, CT, USA). Desalted peptides were diluted 1:1 with 100% acetonitrile, flash-frozen in liquid nitrogen, and lyophilized. Samples were stored at −80 °C immediately following drying to prevent ADPr hydrolysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!